Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No. Don't agree with that. Bright days are ahead!!
Because it's science meant for investors and not science meant for science. That's why.
It doesn't matter. All the Canadian pot stocks have promotion. Do you really think they got to multi billion dollar market caps on their own. That includes the best such as Aphria
I recently met the CEO at a conference and was very impressed.
Where will it be in 6 months?
I guess the only question is the market cap. Any comments?
Thank you. great article
RELEVIUM’S BIOGANIX® NOW LIVE ON AMAZON.CO.UK
September 20 2018 - MONTREAL, QUEBEC – Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Bioganix® brand is now available for purchase in the United Kingdom (“UK”) on the Amazon.co.uk platform.
As announced on April 5, 2018, the Company has begun selling its Bioganix® nutraceutical products in the UK. The Company experienced some delays during the onboarding process but is now fully operational with some of the current highest volume sellers in Amazon.com, which include: Pure Forskolin, White Kidney Bean Extract, BioPro 50 and Turmeric Curcumin. The product line will expand as inventory becomes available and will commence preparing to expand to other European countries such as Germany, France, Italy and Spain.
Aurelio Useche, CEO of Relevium stated: “Now that we have established a presence in the European market, it is anticipated that further regional rollouts will be less time consuming.” Mr. Useche continued: “We believe that the European market will be an exceptional opportunity for all Relevium brands be it for Bioganix® or others. The Operations Team is seeing a significant opportunity and we have high expectations for our core nutraceutical line, as well as, CBD infused and formulated products”
About Relevium Technologies
Relevium is a publicly-traded company that operates in the $3.7 trillion-dollar worldwide wellness industry. Relevium is focused on the development, acquisition, marketing and sale of consumer products that are derived from cannabis and industrial hemp and other ingredients that are generally accepted as safe. The Company uses cannabinoids and ingredients that have achieved GRAS status (generally accepted as safe) to create brands that are sold via wholesale channels, retail channels and online distribution.
Relevium markets its products as dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals. The Company plans on unveiling a complete line of dietary supplements for consumers derived from Cannabis Sativa and Cannabis Indica. The Company’s initial focus will be on creating a full spectrum extract rich in CBD (cannabidiol) which will be marketed and sold throughout Europe and North America. Relevium is also focused on developing a complete line of supplements, nutraceuticals, sports nutrition and cosmeceuticals. Relevium’s products and brands such as Bioganix® have achieved market penetration and now sold at some of the world’s largest retailers such as Walmart.com.
Cautionary Note Regarding Forward-Looking Statements This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will be able to apply for and ultimately obtain an ACMPR licence, the proposed business of Biocannabix will develop as anticipated, that the Company will raise sufficient funds to develop the Biocannabix business, and that the Company will obtain all requisite regulatory approvals. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward
looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed business developments may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche President and CEO
For more information about this press release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES INC Email: investors@releviumcorp.com Website: www.releviumtechnologies.com Like us on Facebook Follow us on Twitter Follow us on LinkedIn
Thriving Cannabis Testing Market Excellent News for Cannabix
https://trueindustrynews.com/cannabis-testing-market-is-thriving-according-to-new-report-opportunities-rise-for-stakeholders/
Nutritional High Positions Itself to be Major Player in California
https://globenewswire.com/news-release/2018/09/06/1566438/0/en/Nutritional-High-Commences-Manufacturing-at-Its-FLI-Labs-NorCal-Facility-in-Sacramento-California.html
TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce that operations have started at its "FLI Labs NorCal" manufacturing facility in Sacramento, California.
FLI Labs NorCal, owned by the Company's wholly-owned subsidiary Pasa Verde LLC ("Pasa Verde"), will manufacture a wide range of products under Nutritional High's FLI brand. Initial product offering will include micro dosed press tabs, vape cartridges, syringes and dab jars. Following the initial launch, FLI Labs NorCal will roll out FLI-branded cannabis-infused edible products that will include chocolates and other innovative products. Pasa Verde holds a Temporary Type 6 License with the California Department of Public Health.
High Velocity of Market Penetration
Jim Frazier, CEO of Nutritional High, commented: "This is a long-awaited day for Nutritional High and we are all excited to start production at Pasa Verde's newly christened "FLI Labs NorCal" facility and launch the FLI-branded products into the California marketplace from our own facility. Operating our own production in California will allow us to increase our velocity of FLI products into the market and significantly expand production delivery capabilities, the number of SKU's we can offer, and reduce our unit costs. With over 17,000 square feet of manufacturing space, FLI Labs NorCal will produce a substantial amount of product that will help us gain current market share and give us the ability, through innovation, to build new markets that captivate consumers by supplying high quality products and unique experiences."
Mr. Frazier continued: "FLI Labs NorCal is a key strategic piece of Nutritional High's corporate vision in California and we will continue to work on expanding our footprint with additional strategic acquisitions in the near future. With Calyx Distribution providing full sales support and distribution services we feel that our FLI-branded products will take the California market by storm and create tremendous opportunity for Nutritional High to gain market share quickly."
David Posner, Chairman of Nutritional High, commented as follows: "This is a great day for Nutritional High and now all of the hard work that everyone has put into the vision has paid off. California is a key focus for Nutritional High and we are anxious to take the next steps and continue to build shareholder value."
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
The Company follows a vertically integrated model with a fully developed strategy for acquisitions in extraction, production, sales, and distribution sectors of the cannabis industry. Nutritional High has brought its flagship FLÏ™ edibles and extracts product line from production to market in California through its wholly owned manufacturer, Pasa Verde LLC and its wholly owned distributor Calyx Brands Inc., and Colorado where its products are manufactured by a licensed producer. The Company also owns a 50% interest in The Clinic Effingham, an Illinois dispensary, and is entering the Nevada, Washington State, Oregon and Canadian markets in the near future.
For updates on the Company's activities and highlights of the Company's press releases and other media coverage, please follow Nutritional High on Facebook, Twitter, Instagram and Google+ or visit www.nutritionalhigh.com.
For further information, please contact:
David Posner
Chairman of the Board
Nutritional High International Inc.
647-985-6727
Email: dposner@nutritionalhigh.com
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such statements include the terms and conditions for future payments to the Vendor and to FMI; management's plan to integrate the Pasa Verde team into its operations across its various segments, management's belief that Pasa Verde will help the Company to secure its supply chain and further develop its suite of value added product offerings in the California marketplace, and management's expectation the transaction will improve the Company's cost structure and further enhance its ability to create value for its shareholders. There is no certainty that any of these events will occur. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. For a discussion of these risk factors, please see the Company's interim management's discussion and analysis for the nine months ended April 30, 2018 and the Company's annual management's discussion and analysis for the year ended July 31, 2017 available at www.sedar.com under the Company's profile. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.
WeedMD's Important First Harvest Event
https://factsaboutcbd.org/2018/09/18/weedmd-inc-otcmktswddmf-update-on-first-harvest-event/
Aleafia Investor Presentation
https://cdn2.hubspot.net/hubfs/3928022/v2/investors/aleafia-25-06-2018.pdf?t=1537390658195
Yes and excellent point!!
Beyond solid. This is one undiscovered cannabis company
Big negative but I'm still positive
https://www.fxpips.com/canadas-biggest-losing-marijuana-companies-sept-14-fire-vivo-hip-mari-snn-isol-mym/
Yes and yes. Just saw your post. Awaken Relevium!!
One of the few Canadian cannabis companies with a market cap of $10 million.
Thank you for the information. It is huge!!
We need to clean up the IBOX on this one.
The valuation of this company is still very fair based on what they have. That is my opinion.
Stock was down today but I still like this one!!
I agree 100% and what I also believe is the Candian government understands that first is important. For example, major tobacco will be investing in Canadian companies and not US companies because of the legality in the United States. The most valuable brands will be Canadian.
The chart looks great
Agreed.
I agree. The CEO was recently on the West Coast at an industry conference. Stay tuned.
They have to learn how to market the story!!
Agreed but the board is asleep.
This company also make have the most recognizable and marketable company name in the entire space. Brilliant!!
That is correct. Been investing is this space for over 5 years. Loved the numbers.
Saw the CEO give a presentation a few months back and I was very impressed.
They need a better PR effort in my opinion.
I saw that and I agree
Is this stock undervalued or overvalued. Opinions please
I agree and I think the attention is just staring
Management team is very competent
There us huge money coming into the stock. Look at the dollar volume.
Hopefully it starts ar $45
I agree. The Walmart.com connection is a significant distribution outlet. Walmart has been selling hemp-based products for awhile. Although they won't accept CBD, there is a big opportunity for Relevium going forward as far as a massive distribution outlet. This may be a small Nutiva right now and the opportunity is very significant.
To be fair, the other side of the argument.